Availability of quality-of-life results for clinical decisions: an evolving scenario.
作者信息
Di Maio Massimo
机构信息
Department of Oncology, University of Turin, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
出版信息
BMJ Oncol. 2024 Jul 11;3(1):e000406. doi: 10.1136/bmjonc-2024-000406. eCollection 2024.
Abstract
摘要
相似文献
1
Availability of quality-of-life results for clinical decisions: an evolving scenario.用于临床决策的生活质量结果的可用性：一个不断演变的情况。
BMJ Oncol. 2024 Jul 11;3(1):e000406. doi: 10.1136/bmjonc-2024-000406. eCollection 2024.
2
Applicability of randomized trials in radiation oncology to standard clinical practice.随机临床试验在放射肿瘤学中对标准临床实践的适用性。
Cancer. 2013 Aug 15;119(16):3092-9. doi: 10.1002/cncr.28149. Epub 2013 May 14.
3
Gastrointestinal tumor board: an evolving experience in Tehran Cancer Institute.胃肠肿瘤多学科会诊：德黑兰癌症研究所的发展历程
Acta Med Iran. 2013 May 7;51(4):270-3.
4
Trends in end-of-life decisions among patients dying in a university hospital oncology ward after implantation of a palliative outpatient clinic.在一所大学附属医院肿瘤科病房中，在姑息门诊植入后死亡的患者的临终决策趋势。
Acta Oncol. 2022 Jul;61(7):881-887. doi: 10.1080/0284186X.2022.2063068. Epub 2022 Apr 25.
5
Evolving oncology care management trends in the United States: A survey among health care decision makers.美国肿瘤护理管理的发展趋势：一项针对医疗保健决策者的调查
J Manag Care Spec Pharm. 2024 Aug;30(8):825-833. doi: 10.18553/jmcp.2024.30.8.825.
6
Cancer Trials Ecosystem in India-Ready for Prime Time?印度的癌症临床试验生态系统——是否已经准备好迎接黄金时代？
JCO Glob Oncol. 2024 Jun;10:e2300405. doi: 10.1200/GO.23.00405.
7
Comparing doctors' legal compliance across three Australian states for decisions whether to withhold or withdraw life-sustaining medical treatment: does different law lead to different decisions?比较澳大利亚三个州的医生在决定是否 withholding 或 withdrawing 维持生命的医疗treatment 时的法律合规性：不同的法律是否会导致不同的决策？
BMC Palliat Care. 2017 Nov 28;16(1):63. doi: 10.1186/s12904-017-0249-1.
8
A multiple-scenario assessment of the effect of a continuous-care, guideline-based decision support system on clinicians' compliance to clinical guidelines.基于指南的持续护理决策支持系统对临床医生遵循临床指南情况影响的多情景评估。
Int J Med Inform. 2015 Apr;84(4):248-62. doi: 10.1016/j.ijmedinf.2015.01.004. Epub 2015 Jan 17.
9
Integrating palliative care into the evolving landscape of oncology.将姑息治疗整合到肿瘤学的不断发展的领域中。
Curr Probl Cancer. 2023 Oct;47(5):101013. doi: 10.1016/j.currproblcancer.2023.101013. Epub 2023 Sep 6.
10
Scenario analysis and multi-criteria decision analysis to explore alternative reimbursement pathways for whole genome sequencing for blood cancer patients.情景分析和多准则决策分析探索血液癌症患者全基因组测序的替代报销途径。
J Cancer Policy. 2024 Sep;41:100501. doi: 10.1016/j.jcpo.2024.100501. Epub 2024 Aug 12.
引用本文的文献
1
Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review.肿瘤临床试验及临床决策中健康相关生活质量测量与生存终点之间的关联：一项叙述性综述
Pharmaceut Med. 2025 May 14. doi: 10.1007/s40290-025-00568-9.
本文引用的文献
1
Quality of life assessment using patient-reported outcome (PRO) measures: still a Cinderella outcome?使用患者报告结局（PRO）指标进行生活质量评估：仍是一个被忽视的结果吗？
Ann Oncol. 2018 Dec 1;29(12):2286-2287. doi: 10.1093/annonc/mdy481.
2
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.健康相关生活质量评估和报告的不足：2012 年至 2016 年发表的肿瘤随机 III 期试验的系统评价。
Ann Oncol. 2018 Dec 1;29(12):2288-2295. doi: 10.1093/annonc/mdy449.
3
Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada.将患者体验纳入美国、欧洲和加拿大的监管决策中。
Lancet Oncol. 2018 May;19(5):e267-e274. doi: 10.1016/S1470-2045(18)30097-4.
4
ESMO-Magnitude of Clinical Benefit Scale version 1.1.ESMO-临床获益量表 1.1 版
Ann Oncol. 2017 Oct 1;28(10):2340-2366. doi: 10.1093/annonc/mdx310.
Zotero 插件